Research Directory

Ipsen aspires to role as speciality oncology player

Read more

Drugs for orphan diseases are no longer rare

Read more

JP Morgan forum ends on a positive note

Read more

Outlook brightens for European cell and gene therapy industry

Read more

Liquid biopsy comes of age

Read more

Europe's biotechs succeed without partners

Read more

Biotech industry looks nervously into 2016

Read more

Biotech enters 2015 on an upswing

Read more

Commentary: The outlook for biotech seems rosy - for now

Read more

Financial thermometer rises at JP Morgan meeting

Read more